Lh. Pang et al., IMPAIRED CAMP PRODUCTION IN HUMAN AIRWAY SMOOTH-MUSCLE CELLS BY BRADYKININ - ROLE OF CYCLOOXYGENASE PRODUCTS, American journal of physiology. Lung cellular and molecular physiology, 19(2), 1998, pp. 322-329
Interleukin (IL)-1 beta impairs human airway smooth muscle (ASM) cell
cAMP responses to isoproterenol (Iso). We investigated if bradykinin (
BK) could cause a similar effect and the role of cyclooxygenase (COX)
products in this event, since we have recently reported that BK, like
IL-1 beta, also causes COX-2 induction and prostanoid release in human
ASM cells. BK pretreatment significantly attenuated Iso-induced cAMP
generation in a time- and concentration-dependent manner. cAMP generat
ion by prostaglandin (PG) E-2 but not by forskolin was also impaired.
The COX inhibitor indomethacin completely prevented the impairment, wh
ereas the selective COX-2 inhibitors NS-398 and nimesulide, protein sy
nthesis inhibitors cycloheximide and actinomycin D, and steroid dexame
thasone were all partially effective. The impairment was mimicked by t
he B-2 agonist [Tyr(Me)(8)]BK, the Ca2+ ionophore A-23187, and PGE(2)
and prevented by the BS antagonist HOE-140, but anti-IL-1 beta serum w
as ineffective. The results indicate that BK impairs human ASM cell re
sponses to Iso, and the effect is largely mediated by B-2 receptor-rel
ated COX product release via both COX isoforms and is independent of I
L-1 beta.